Enantiomeric separation of dihydroxyphenyl-alanine (DOPA), methyldihydroxyphenylalanine (MDOPA) and hydrazinomethyldihydroxyphenyl-alanine (CDOPA) by using capillary electrophoresis with sulfobutyl ether-β-cyclodextrin as a chiral selector

This publication has 15 references indexed in Scilit:

• Stereoselective screening for and confirmation of urinary enantiomers of amphetamine, methamphetamine, designer drugs, methadone and selected metabolites by capillary electrophoresis
  Electrophoresis, 1999
• Simultaneous stereoselective analysis by capillary electrophoresis of tramadol enantiomers and their main phase I metabolites in urine
  Journal of Chromatography A, 1999
• Direct high-performance liquid chromatographic determination of the enantiomeric purity of levodopa and methyldopa: comparison with pharmacopoeial polarimetric methods
  Journal of Pharmaceutical and Biomedical Analysis, 1999
• Chiral capillary electrophoresis–electrospray mass spectrometry coupling with charged cyclodextrin derivatives as chiral selectors
  Journal of Chromatography A, 1998
• Sulfated cyclodextrins for the chiral separations of catecholamines and related compounds in the reversed electrophoretic polarity mode
  Chirality, 1996
• Current regulatory (draft) guidance on chiral medicinal products: Canada, EEC, Japan, United States
  Chirality, 1994
• Clinical pharmacology through the looking glass: reflections on the racemate vs enantiomer debate.
  British Journal of Clinical Pharmacology, 1991
• Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology
  European Journal of Clinical Pharmacology, 1984
• Modification of Parkinsonism — Chronic Treatment with L-Dopa
  New England Journal of Medicine, 1969
• Inhibition of dopa decarboxylase by the hydrazino analog of α-methyldopa
  Biochemical Pharmacology, 1962